We are live on
!
Find out more
EHWM
Eads & Heald Wealth Management Portfolio holdings
AUM
$204M
1-Year Est. Return
28.27%
This Fund
S&P 500
This Quarter
Est. Return
+9.16%
1 Year Est. Return
+28.27%
3 Year Est. Return
+84.36%
5 Year Est. Return
+119.71%
10 Year Est. Return
+418.2%
AUM
$202M
AUM Growth
+$5.53M
(+2.8%)
Cap. Flow
-$6.16M
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
19.08%
Holding
143
New
5
Increased
30
Reduced
95
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hubbell
HUBB
|
+$982K |
| 2 |
Accenture
ACN
|
+$562K |
| 3 |
Helmerich & Payne
HP
|
+$456K |
| 4 |
Elevance Health
ELV
|
+$338K |
| 5 |
Toll Brothers
TOL
|
+$205K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$533K |
| 2 |
NVIDIA
NVDA
|
+$488K |
| 3 |
UnitedHealth
UNH
|
+$430K |
| 4 |
Amphenol
APH
|
+$401K |
| 5 |
D.R. Horton
DHI
|
+$371K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.17% |
| 2 | Industrials | 15.56% |
| 3 | Healthcare | 13.31% |
| 4 | Consumer Discretionary | 11.98% |
| 5 | Consumer Staples | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Graco
GGG
$13.3B
| $274K | 0.14% |
3,190
| – | – |
|
127
Chemed
CHE
$7.09B
| $273K | 0.13% |
561
-5
| -0.9% | -$2.85K |
|
128
Shell
SHEL
$244B
| $267K | 0.13% |
3,791
-105
| -3% | -$7.04K |
|
129
Williams Companies
WMB
$87.6B
| $250K | 0.12% |
3,982
-1,020
| -20% | -$60.2K |
|
130
Lincoln National
LNC
$8.91B
| $244K | 0.12% |
7,065
-285
| -4% | -$9.32K |
|
131
Rio Tinto
RIO
$165B
| $235K | 0.12% |
4,028
-135
| -3% | -$7.97K |
|
|
132
Toll Brothers
TOL
$14.5B
| $226K | 0.11% |
+1,976
| New | +$205K |
|
133
Bank of America
BAC
$443B
| $223K | 0.11% |
+4,707
| New | +$198K |
|
134
Duke Energy
DUK
$96B
| $210K | 0.1% |
1,780
-144
| -7% | -$17K |
|
135
Alcoa
AA
$12.6B
| – | – |
-7,783
| Closed | -$237K |
|
136
BP
BP
$107B
| – | – |
-8,547
| Closed | -$289K |
|
137
Charles River Laboratories
CRL
$12.6B
| – | – |
-1,548
| Closed | -$233K |
|
138
Dollar Tree
DLTR
$24.7B
| – | – |
-3,600
| Closed | -$270K |
|
139
Gilead Sciences
GILD
$163B
| – | – |
-2,749
| Closed | -$308K |
|
140
McCormick & Company Non-Voting
MKC
$14.1B
| – | – |
-2,500
| Closed | -$206K |
|
141
Pfizer
PFE
$145B
| – | – |
-9,325
| Closed | -$236K |
|
142
Philip Morris
PM
$296B
| – | – |
-1,269
| Closed | -$201K |
|
143
Prudential Financial
PRU
$41.6B
| – | – |
-1,896
| Closed | -$212K |
|
Similar funds
CAM
KFA
II
AA
WA1
OF
TCM
PKC
Eads & Heald Wealth Management's Q2 2025 Portfolio in Review
As of Q2 2025, Eads & Heald Wealth Management held 143 positions worth $202M, up 2.8% from $197M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Eads & Heald Wealth Management withdrew a net $6.16M in Q2 2025, closing 9 positions and reducing 95 holdings. Its most notable exit was Gilead Sciences, an estimated $308K position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Eads & Heald Wealth Management opened a new position in Hubbell worth $1.08M.
- Eads & Heald Wealth Management's largest Q2 2025 buy was Hubbell: 2,650 shares worth $1.08M.
- Eads & Heald Wealth Management added most to Accenture in Q2 2025, an estimated $562K increase.
- Eads & Heald Wealth Management's biggest Q2 2025 reduction was Netflix, cutting an estimated $533K.
- Eads & Heald Wealth Management fully exited Gilead Sciences in Q2 2025, selling an estimated $308K.
- Eads & Heald Wealth Management's ten largest holdings make up 19% of its $202M portfolio in Q2 2025.
- Eads & Heald Wealth Management opened 5 new positions and closed 9 in Q2 2025.
- Eads & Heald Wealth Management's portfolio value rose 2.8% quarter-over-quarter to $202M.
Based on Eads & Heald Wealth Management's 13F filing for Q2 2025, filed 22 Jul 2025.